Loading clinical trials...
Loading clinical trials...
Long Term Follow Up for Patients Who Have Received Allogeneic Stem Cell Transplantation of NiCord®/CordIn™, Umbilical Cord Blood-derived Ex Vivo Expanded Stem and Progenitor Cells
Conditions
Interventions
NiCord®/CordIn™ (omidubicel)
Locations
10
United States
UCSF Benioff Children's Hospital
Oakland, California, United States
Loyola University, Cardinal Bernardin Cancer Center
Maywood, Illinois, United States
Duke University Medical Center
Durham, North Carolina, United States
Duke University Medical Center
Durham, North Carolina, United States
Vanderbilt
Nashville, Tennessee, United States
University Medical Center Utrecht
Utrecht, Netherlands
Start Date
May 1, 2014
Primary Completion Date
June 29, 2023
Completion Date
June 29, 2023
Last Updated
October 23, 2024
Lead Sponsor
Gamida Cell ltd
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions